Cloning, characterization, and functional studies of a human 40-kDa catecholamine-regulated protein: Implications in central nervous system disorders

Cell Stress and Chaperones

Volumn 14, Issue 6, 2009, Pages 555-567

  Gabriele, Joseph ^a   Pontoriero, Giuseppe F ^a   Thomas, Nancy ^a   Thomson, Christy A ^b   Skoblenick, Kevin ^a   Pristupa, Zdenek B ^a   Mishra, Ram K ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Catecholamine regulated protein; Cns disorders; Dopamine; Molecular chaperone; Mortalin

Indexed keywords

CATECHOLAMINE REGULATED PROTEIN 40; CHAPERONIN; COMPLEMENTARY DNA; DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; HALOPERIDOL; HEAT SHOCK PROTEIN 70; MORTALIN; RECOMBINANT CATECHOLAMINE REGULATED PROTEIN 40; RNA LIGASE; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; EMBRYO; EXPRESSED SEQUENCE TAG; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOLOCALIZATION; MOLECULAR CLONING; MOUSE; NEUROBLASTOMA CELL; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN FUNCTION;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CATTLE; CELL LINE, TUMOR; CENTRAL NERVOUS SYSTEM DISEASES; CLONING, MOLECULAR; DOPAMINE; HALOPERIDOL; HSP70 HEAT-SHOCK PROTEINS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; NEURONS; RECOMBINANT PROTEINS; RNA SPLICING; SEQUENCE HOMOLOGY, NUCLEIC ACID;

BOVINAE;

EID: 77950862634     PISSN: 13558145     EISSN: 14661268     Source Type: Journal    
DOI: 10.1007/s12192-009-0107-z     Document Type: Article

References (46)

1. Bagchi M, Katar M, Maisel H (2001) A heat shock transcription factor like protein in the nuclear matrix compartment of the tissue cultured mammalian lens epithelial, cell. J Cell Biochem. 80:382-387 doi:10.1002/1097-4644(20010301)80: 3<382::AID-JCB120>3.0.CO;2-D (Pubitemid 32141494)
2. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254 doi:10.1016/0003-2697(76)90527-3
3. Buck TM, Wright CM, Brodsky JL (2007) The activities and function of molecular chaperones in the endoplasmic reticulum. Semin Cell Dev Biol 18:751-761 doi:10.1016/j.semcdb.2007.09.001 (Pubitemid 350138451)
4. Calderwood SK, Mambula SS, Gray PJ Jr, Theriault JR (2007) Extracellular heat shock proteins in cell signaling. FEBS Lett 581:3689-3694 doi:10.1016/j.febslet.2007.04.044 (Pubitemid 47081004)
5. Crowe RR, Vieland V (1999) Report of the Chromosome 5 Workshop of the Sixth World Congress on Psychiatric Genetics. Am J Med Genet 88:229-232 doi:10.1002/(SICI)1096-8628(19990618) 88:3<229::AID-AJMG4>3.0.CO;2-B (Pubitemid 29269487)
6. Diano M, Le Bivic A, Hirn M (1987) A method for the production of highly specific polyclonal antibodies. Anal Biochem 166:224-229 doi:10.1016/0003- 2697(87)90568-9
7. Dobson CM (2004) Principles of protein folding, misfolding and aggregation. Semin Cell Dev Biol 15:3-16 doi:10.1016/j.semcdb.2003.12.008 (Pubitemid 38177363)
8. Gabriele J, Rajaram M, Zhang B, Sharma S, Mishra RK (2002) Modulation of a 40-kDa catecholamine-regulated protein following D-amphetamine treatment in discrete brain regions. Eur J Pharmacol 453:13-19 doi:10.1016/S0014-2999(02) 02366-X (Pubitemid 35232449)
9. Gabriele J, Culver K, Sharma S, Zhang B, Szechlman H, Mishra R (2003) Asymmetric modulation of a catecholamine-regulated protein in the rat brain, following quinpirole administration. Synapse 49:261-269 doi:10.1002/syn.10224 (Pubitemid 36927967)
10. Gabriele JP, Chong VZ, Pontonero GF, Mishra RK (2005) Decreased expression of a 40-kDa catecholamine-regulated protein in the ventral striatum of schizophrenic brain specimens from the Stanley Foundation Neuropathology Consortium. Schizophr Res 74:111-119 doi: 10.1016/j.schres.2004.03.025
11. Gabriele J, Thomas N, N-Marandi S, Mishra R (2007) Differential modulation of a 40 kDa catecholamine regulated protein in the core and shell subcompartments of the nucleus accumbens following chronic quinpirole and haloperidol administration in the rat. Synapse 61:835-842 doi:10.1002/syn.20435 (Pubitemid 47328802)
12. Giffard RG, Xu L, Zhao H, Carrico W, Ouyang Y, Qiao Y, Sapolsky R, Steinberg G, Hu B, Yenari MA (2004) Chaperones, protein aggregation, and brain protection from hypoxic/ischemic injury. J Exp Biol 207:3213-3220 doi:10.1242/jeb.01034 (Pubitemid 39275295)
13. Hillion J, Canals M, Torvinen M, Casado V, Scott R, Terasmaa A, Hansson A, Watson S, Olah ME, Mallol J et al. (2002) Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors. J Biol Chem 277:18091-18097 doi:10.1074/jbc.M107731200
14. Hong KS, Mclnnes LA, Service SK, Song T, Lucas J, Silva S, Fournier E, Leon P et al. (2004) Genetic mapping using haplotype and model-free linkage analysis supports previous evidence for a locus predisposing to severe bipolar disorder at 5q31-33. Am J Med. Genet. B Neuropsychiatr Genet. 125B:83-86 doi:00.1002/ajmg.b.20091
15. Irvine GB, El-Agnaf OM, Shankar GM, Walsh DM (2008) Protein aggregation in the brain: the molecular basis for Alzheimer's and Parkinson's diseases. Mol Med. 14:451-464 doi:10.2119/2007-00100.Irvine
16. Jin J, Meredith GE, Chen L, Zhou Y, Xu J, Shie FS, Lockhart P, Zhang J (2005) Quantitative proteomic analysis of mitochondrial proteins: relevance to Lewy body formation and Parkinson's disease. Brain Res Mol Brain Res 134:119-138 doi:10.1016/j.molbrainres.2004.10.003 (Pubitemid 40403644)
17. Jin J, Hulette C, Wang Y, Zhang T, Pan C, Wadhwa R, Zhang J (2006) Proteomic identification of a stress protein, mortalin/mthsp70/GRP75: relevance to Parkinson disease. Mol Cell Proteomics 5:1193-1204 doi: 10.1074/mcp.M500382- MCP200 (Pubitemid 44103391)
18. Kaul SC, Reddel RR, Mitsui Y, Wadhwa R (2001) An N-terminal region of mot-2 binds to p53 in vitro. Neoplasia 3:110-114 doi:10.1038/sj.neo.7900139 (Pubitemid 32410351)
19. Kaul SC, Taira K, Pereira-Smith OM, Wadhwa R (2002) Mortalin: present and prospective. Exp Gerontol 37:1157-1164 doi:10.1016/S0531-5565(02)00135-3
20. Kaul SC, Deocaris CC, Wadhwa R (2007) Three faces of mortalin: a housekeeper, guardian and killer. Exp Gerontol 42:263-274 doi:10.1016/j.exger. 2006.10.020
21. Lanneau D, Brunet M, Frisan E, Solary E, Fontenay M, Garrido C (2008) Heat shock proteins: essential proteins for apoptosis regulation. J Cell Mol Med 12:743-761 doi:10.1111/j.1582-4934.2008.00273.x
22. Lewis CM, Levinson DF, Wise LH, DeLisi LE, Straub RE, Hovatta I, Williams NM, Schwab SG et al. (2003) Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: schizophrenia. Am J Hum Genet 73:34-48 doi:10.1086/376549
23. Liberek K, Lewandowska A, Zietkiewicz S (2008) Chaperones in control of protein disaggregation. EMBO J 27:328-335 doi:10.1038/sj.emboj.7601970
24. Min JN, Whaley RA, Sharpless NE, Lockyer P, Portbury AL, Patterson C (2008) CHIP deficiency decreases longevity, with accelerated aging phenotypes accompanied by altered protein quality control. Mol Cell Biol 28:4018-4025 doi:10.1128/MCB.00296-08 (Pubitemid 351812987)
25. Modi PI, Kashyap A, Nair VD, Ross GM, Fu M, Savelli JE, Marcotte ER, Barlas C et al. (1996) Modulation of brain catecholamine absorbing proteins by dopaminergic agents. Eur J Pharmacol 299:213-220 doi:10.1016/0014-2999(95)00849- 7 (Pubitemid 26104659)
26. Muchowski PJ, Wacker JL (2005) Modulation of neurodegeneration by molecular chaperones. Nat Rev Neurosci 6:11-22 doi:10.1038/nm1587
27. Nair VD, Mishra RK (2001) Molecular cloning, localization and characterization of a 40-kDa catecholamine-regulated protein. J Neurochem 76:1142-1152 doi:10.1046/j.1471-4159.2001.00117.x (Pubitemid 32167388)
28. Nair VD, Niznik HB, Mishra RK (1996) Interaction of NMDA and dopamine D2L receptors in human neuroblastoma SH-SY5Y cells. J Neurochem 66:2390-2393 (Pubitemid 26159073)
29. Ohtsuka K, Suzuki T (2000) Roles of molecular chaperones in the nervous system. Brain Res Bull 53:141-146 doi:10.1016/S0361-9230(00)00325-7
30. Ross GM, McCarry BE, Thakur S, Mishra RK (1993) Identification of novel catecholamine absorbing proteins in the central nervous system. J Mol Neurosci 4:141-148 doi:10.1007/BF02782497 (Pubitemid 2017694)
31. Ross GM, McCarry BE, Mishra RK (1995) Covalent affinity labeling of brain catecholamine-absorbing proteins using a high-specific-activity substituted tetrahydronaphthalene. J Neurochem 65:2783-2789
32. Sharan N, Nair VD, Mishra RK (2001) Modulation of a 40-kDa catecholamine regulated protein by dopamine receptor antagonists. Eur J Pharmacol 413:73-79 doi:10.1016/S0014-2999(01)00736-1 (Pubitemid 32150060)
33. Sharan N, Chong VZ, Nair VD, Mishra RK, Hayes RJ, Gardner EL (2003) Cocaine treatment increases expression of a 40 kDa catecholamine-regulated protein in discrete brain regions. Synapse 47:33-44 doi:10.1002/syn.10140 (Pubitemid 35424541)
34. Sherman MY, Goldberg AL (2001) Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases. Neuron 29:15-32 doi:10.1016/S0896-6273(01)00177-5
35. Shi M, Jin J, Wang Y, Beyer RP, Kitsou E, Albin RL, Gearing M, Pan C, Zhang J (2008) Mortalin: a protein associated with progression of Parkinson disease? J Neuropathol Exp Neurol 67:117-124 doi: 10.1097/nen.0b013e3181.63354a
36. Sklar P, Pato MT, Kirby A, Petryshen TL, Medeiros H, Carvalho C, Macedo A, Dourado A et al. (2004) Genome-wide scan in Portuguese Island families identifies 5q31-5q35 as a susceptibility locus for schizophrenia and psychosis. Mol Psychiatry 9:213-218 doi:10.1038/sj.mp.4001418
37. Soti C, Csermely P (2002a) Chaperones and aging: role in neurodegeneration and in other civilizational diseases. Neurochem Int 41:383-389 doi:10.1016/S0197-0186(02)00043-8 (Pubitemid 35232323)
38. Soti C, Csennely P (2002b) Chaperones come of age. Cell Stress Chaperones 7:186-190 doi:10.1379/1466-1268(2002)007<0186:CCOA>2.0.CO;2
39. Tomala K, Korona R (2008) Molecular chaperones and selection against mutations. Biol Direct 3:5 doi:10.1186/1745-6150-3-5
40. van Noort JM (2008) Stress proteins in CNS inflammation. J Pathol 214:267-275 doi:10.1002/path.2273
41. Verma V, Mann A, Costain W, Pontoriero G, Castellano JM, Skoblenick K, Gupta SK, Pristupa Z et al. (2005) Modulation of agonist binding to human dopamine receptor subtypes by L-prolyl-L-leucyl-glycinamide and a peptidomimetic analog. J Pharmacol Exp Ther 315:1228-1236 doi:10.1124/jpet.105.091256
42. Wadhwa R, Kaul SC, Ikawa Y, Sugimoto Y (1991) Protein markers for cellular mortality and immortality. Mutat Res 256:243-254
43. Wadhwa R, Kaul SC, Ikawa Y, Sugimoto Y (1993a) Identification of a novel member of mouse hsp70 family. Its association with cellular mortal phenotype. J Biol Chem 268:6615-6621
44. Wadhwa R, Kaul SC, Sugimoto Y, Mitsui Y (1993b) Spontaneous immortalization of mouse fibroblasts involves structural changes in senescence inducing protein, mortalin. Biochem Biophys Res Commun 197:202-206 doi:10.1006/bbrc.1993.2461 (Pubitemid 23358897)
45. Wadhwa R, Yaguchi T, Hasan MK, Mitsui Y, Reddel RR, Kaul SC (2002) Hsp70 family member, mot-2/mthsp70/GRP75, binds to the cytoplasmic sequestration domain of the p53 protein. Exp Cell Res 274:246-253 doi:10.10067excr.2002.5468
46. Xie H, Hu Z, Chyna B, Horrigan SK Westbrook CA (2000) Human mortalin (HSPA.9): a candidate for the myeloid leukemia tumor suppressor gene on 5q31. Leukemia 14:2128-2134 doi:10.1038/sj.leu.2401935 (Pubitemid 32042252)